$EXEL Cashflow Statement | Understand Stock

$EXEL

$66.31 +$0.96 (1.47%) Live

$EXEL Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated statements of cash flows

In millions of USD, except per-share amounts

	FY2025 12 months to Jan 2, 2026	FY2024 12 months to Jan 3, 2025	FY2023 12 months to Dec 29, 2023	FY2022 12 months to Dec 30, 2022	FY2021 12 months to Dec 31, 2021
Net income
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
Impairment of long-lived assets
Stock-based compensation
Non-cash lease expense
Deferred taxes
Acquired in-process research and development technology
Other, net
Changes in operating assets and liabilities:
Trade receivables, net
Inventory
Prepaid expenses and other assets
Deferred revenue
Accrued collaboration liabilities
Accounts payable and other liabilities
Net cash provided by operating activities
Cash flows from investing activities:
Purchases of marketable securities
Proceeds from maturities and sales of marketable securities
Purchases of property, equipment and other, net
Acquired in-process research and development technology
Net cash provided by (used in) investing activities
Cash flows from financing activities:
Payments for repurchases of common stock
Proceeds from issuance of common stock under the equity incentive plan and stock purchase plan
Taxes paid related to net share settlement of equity awards
Other, net
Net cash used in financing activities

Net increase (decrease) in cash and cash equivalents
Cash and cash equivalents at beginning of period
Cash and cash equivalents at end of period
Supplemental cash flow disclosures:
Net cash paid for income taxes
Non-cash operating activities:
Right-of-use assets obtained in exchange for lease obligations
Accounts receivable for unsettled investment sales
Impairment of right-of-use assets
Non-cash investing activity:
Unpaid liabilities incurred for purchases of in-process research and development technology
Unpaid liabilities incurred for purchases of property and equipment
Unpaid liabilities incurred for purchases of investment

Comments